(Q40504313)

21 September 2017

1 reference

title

Eicosanoids and the immunology of cancer (English)

1 reference

21 September 2017

M R Young

1

1 reference

PubMed ID

7712595

21 September 2017

language of work or name

1 reference

1 December 1994

1 reference

Cancer and Metastasis Reviews

21 September 2017

1 reference

21 September 2017

13

1 reference

21 September 2017

3-4

1 reference

21 September 2017

337-348

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00666103

21 September 2017

0 references

cites work

Systemic macrophage activation with liposome-entrapped immunomodulators for therapy of cancer metastasis

1 reference

12 December 2020

Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor)

1 reference

12 December 2020

The LMI test in colon, breast and lung cancer long survivors

1 reference

12 December 2020

Contribution of monocytes to the decreased lymphoproliferative response to phytohemagglutinin in patients with lung cancer

1 reference

12 December 2020

Protein phosphatases limit tumor motility

1 reference

12 December 2020

Altered eicosanoid levels in human colon cancer

1 reference

12 December 2020

Regulation of tumor-induced myelopoiesis and the associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma by prostaglandin E2.

1 reference

12 December 2020

Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma

1 reference

12 December 2020

Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.

1 reference

12 December 2020

T-cell subsets and cytokines in parasitic infections

1 reference

12 December 2020

In vitro and in vivo activated T cells display increased sensitivity to PGE2.

1 reference

12 December 2020

A regimen of surgical adjuvant immunotherapy for cancer with interleukin 2 and lymphokine-activated killer cells. Basis, clinical toxicity, and immunomodulatory effects

1 reference

12 December 2020

Effect of LTB4 on the inhibition of natural cytotoxic activity by PGE2

1 reference

12 December 2020

Tumour dormancy: initiation, maintenance and termination in animals and humans.

1 reference

12 December 2020

Head and Neck Squamous Cell Carcinoma Cell Line-Induced Suppression of in vitro Lymphocyte Proliferative Responses

1 reference

12 December 2020

Interleukin-2 in cancer treatment: disappointing or (still) promising? A review

1 reference

12 December 2020

Cytokines and suppressor macrophages cause tumor-bearing host CD8+ T cells to suppress recognition of allogeneic and syngeneic MHC class II molecules

1 reference

12 December 2020

Tumor dormancy and the effect of selected drugs on the tumor-dormant state

1 reference

12 December 2020

Immunotherapy with intralesional and systemic interleukin-2 of patients with non-small-cell lung cancer

1 reference

12 December 2020

Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells

1 reference

12 December 2020

Bronchogenic carcinoma: immunologic aspects

1 reference

12 December 2020

Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor beta

1 reference

12 December 2020

Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: toxicity and immunomodulatory effects

1 reference

12 December 2020

Activation of protein kinase A increases the in vitro invasion, migration, and adherence to reconstituted basement membrane by Lewis lung carcinoma tumor cells

1 reference

12 December 2020

Update on immunology of head and neck cancer.

1 reference

12 December 2020

Promotion of metastases by tumor necrosis factor in rats bearing Dunning R3327 MAT-LyLu prostatic cancer

1 reference

12 December 2020

Effects of indomethacin, cytokines, and cyclosporin A on tumor growth and the subsequent development of cancer cachexia

1 reference

12 December 2020

Effect of prostaglandin E2 (PGE2) on IL-3/granulocyte-macrophage colony-stimulating factor production by T helper cells. Mode of stimulation and presence of costimulation can determine response to PGE2.

1 reference

12 December 2020

Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2

1 reference

12 December 2020

Regulation of human cytolytic lymphocyte responses by interleukin-12

1 reference

12 December 2020

Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma

1 reference

12 December 2020

In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients

1 reference

12 December 2020

Tumoricidal activation of murine resident peritoneal macrophages by interleukin 2 and tumor necrosis factor alpha

1 reference

12 December 2020

Administration of a prostaglandin synthetase inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.

1 reference

12 December 2020

Effects of fish oil and corn oil diets on prostaglandin-dependent and myelopoiesis-associated immune suppressor mechanisms of mice bearing metastatic Lewis lung carcinoma tumors

1 reference

12 December 2020

Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo

1 reference

12 December 2020

Chemically induced hypotension increases PGE2 release and depresses macrophage antigen presentation

1 reference

12 December 2020

Regulation of phospholipase A2 activation and arachidonic acid metabolism in an interleukin-3–dependent macrophage-like cell line

1 reference

12 December 2020

Differential effects of prostaglandins on macrophage activation induced by calcium ionophore A23187 or IFN-gamma

1 reference

12 December 2020

Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer

1 reference

12 December 2020

The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF

1 reference

12 December 2020

Sensitivity of tumoricidal function in macrophages from different anatomical sites of cancer patients to modulation of arachidonic acid metabolism

1 reference

12 December 2020

Selective homing of phenotypically lytic cells within nasopharyngeal carcinoma biopsies: numerous CD8- and CD16-positive cells in the tumor

1 reference

12 December 2020

Prostaglandin E2 receptor activity and susceptibility to natural killer cells

1 reference

12 December 2020

Interferon-gamma reduces tumor-induced Ia- macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-alpha

1 reference

12 December 2020

Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells

1 reference

12 December 2020

Interleukin 2 acutely induces platelet and neutrophil-endothelial adherence and macromolecular leakage

1 reference

12 December 2020

Differential induction of prostaglandin E2-dependent and -independent immune suppressor cells by tumor-derived GM-CSF and M-CSF

1 reference

12 December 2020

Technique for the primary culture of human breast cancer cells and measurement of their prostaglandin secretion

1 reference

12 December 2020

Local immunity and metastasis of colorectal carcinoma

1 reference

12 December 2020

Ia- macrophages and cytokine networks contribute to tumor-induced suppression of CD4+ autoreactive T cells

1 reference

12 December 2020

LPS-induced activation of primed murine peritoneal macrophages is modulated by prostaglandins and cyclic nucleotides

1 reference

12 December 2020

Advantages of adoptive chemoimmunotherapy with polyethylene glycol-cultured, antigen-activated, tumor-infiltrated spleen cells for the complete eradication of lethal MOPC-315 plasmacytomas

1 reference

12 December 2020

Effect of indomethacin plus ranitidine in advanced melanoma patients on high-dose interleukin-2

1 reference

12 December 2020

A new view of prostaglandin E regulation of the immune response.

1 reference

12 December 2020

Effect of prostaglandin E on immune function in normal healthy volunteers

1 reference

12 December 2020

Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels

1 reference

12 December 2020

Selective lysis of the autologous tumor by δTCS1+ γ/δ+ tumor-infiltrating lymphocytes from human lung carcinomas

1 reference

12 December 2020

Alternative splicing of human prostaglandin G/H synthase mRNA and evidence of differential regulation of the resulting transcripts by transforming growth factor beta 1, interleukin 1 beta, and tumor necrosis factor alpha

1 reference

12 December 2020

Association of increased tumor cell responsiveness to prostaglandin E2 with more aggressive tumor behavior

1 reference

12 December 2020

Prostaglandin E2 does not inhibit tumoricidal activity of mouse macrophages against adherent tumor cells

1 reference

12 December 2020

Changes in the populations of null, NK1.1+, and Thy1lo lymphocytes in the bone marrow of tumor-bearing mice: effect of indomethacin treatment

1 reference

12 December 2020

Effect of intravenous injection of IL-1 beta on PGE2 levels in several brain areas as determined by microdialysis

1 reference

12 December 2020

Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells

1 reference

12 December 2020

Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.

1 reference

12 December 2020

Regulation by prostaglandin E2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages

1 reference

12 December 2020

Molecular regulation of tumor necrosis factor-alpha and lymphotoxin production in T cells. Inhibition by prostaglandin E2

1 reference

12 December 2020

Phorbol dibutyrate plus ionomycin improves the generation of cytotoxic T cells from draining lymph nodes of patients with advanced head and neck cancer

1 reference

12 December 2020

A difference in prostaglandin-producing ability between cancer cells metastasized into liver and kidney

1 reference

12 December 2020

Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor

1 reference

12 December 2020

Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha

1 reference

12 December 2020

Aspirin use and risk of fatal cancer

1 reference

12 December 2020

Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow

1 reference

12 December 2020

Phase IB clinical trial of anti-CD3 followed by high-dose bolus interleukin-2 in patients with metastatic melanoma and advanced renal cell carcinoma: clinical and immunologic effects

1 reference

12 December 2020

Eradication of spontaneous and experimental adenocarcinoma metastases with chronic indomethacin and intermittent IL-2 therapy.

1 reference

12 December 2020

Modulation of monocyte functions by muramyl tripeptide phosphatidylethanolamine in a phase II study in patients with metastatic melanoma

1 reference

12 December 2020

Regulation of protein kinase A activation and prostaglandin E2-stimulated migration of Lewis lung carcinoma clones

1 reference

12 December 2020

Oligoclonal T lymphocytes infiltrating human lung cancer tissues

1 reference

12 December 2020

Immunomodulation in an apparently non-immunogenic murine tumor

1 reference

12 December 2020

Cytokine modulation of immune activation associated suppression of macrophage cyclooxygenase activity in vivo

1 reference

12 December 2020

IL-12 augments antigen-dependent proliferation of activated T lymphocytes

1 reference

12 December 2020

Lipid-bound sialic acid, prostaglandin E and histamine in head and neck cancer

1 reference

12 December 2020

Intensive recombinant interleukin-2 and alpha-interferon therapy in patients with advanced head and neck squamous carcinoma

1 reference

12 December 2020

Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00666103

1 reference

PubMed ID

7712595

Dimensions Publication ID

21 September 2017

0 references

1 reference

PubMed ID

7712595